Deuterium Capital Management, LLC Chimerix Inc Transaction History
Deuterium Capital Management, LLC
- $47.5 Million
- Q3 2024
A detailed history of Deuterium Capital Management, LLC transactions in Chimerix Inc stock. As of the latest transaction made, Deuterium Capital Management, LLC holds 11,908 shares of CMRX stock, worth $41,439. This represents 0.02% of its overall portfolio holdings.
Number of Shares
11,908
Previous 11,908
-0.0%
Holding current value
$41,439
Previous $10,000
10.0%
% of portfolio
0.02%
Previous 0.02%
Shares
1 transactions
Others Institutions Holding CMRX
# of Institutions
70Shares Held
37MCall Options Held
52.7KPut Options Held
130K-
Ra Capital Management, L.P. Boston, MA8.8MShares$30.6 Million0.11% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.33MShares$15.1 Million0.0% of portfolio
-
Monaco Asset Management Sam4.22MShares$14.7 Million0.58% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny2.4MShares$8.34 Million0.0% of portfolio
-
Armistice Capital, LLC New York, NY2.21MShares$7.68 Million0.03% of portfolio
About CHIMERIX INC
- Ticker CMRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 87,622,896
- Market Cap $305M
- Description
- Chimerix, Inc., a biopharmaceutical company, develops medicines to enhance the lives of patients living with serious diseases. The company's approved product is TEMBEXA (brincidofovir), a lipid conjugate through inhibition of viral DNA synthesis that is developed as a medical countermeasure for smallpox. Its clinical stage development programs i...